Invited Faculty
  • Roy Fleischmann
    Univ. of Texas Southwestern Medical Center
    USA
  • Dr. Fleischmann is Board Certified in Internal Medicine and Rheumatology by the ABIM and is a Master of the American College of Rheumatology. Dr. Fleischmann graduated from Columbia College in NYC and trained in Rheumatology at Columbia Presbyterian Medical Center in NYC. He is a Clinical Professor of Medicine at the University of Texas Southwestern Medical Center in Dallas and has been in the Private Practice of rheumatology since 1975 as well as co-director of the Metroplex Clinical Research Center in Dallas and co-Director of the Division of Rheumatology at the Presbyterian Medical Center in Dallas. He is Editor of Rheumatology and Therapy and on the Editorial Boards of the Annals of Rheumatic Disease, RMD Open and the Journal of Rheumatology and past International Editor of Rheumatology (Oxford). He has been noted to be in the top 5% of reviewers for Arthritis and Rheumatology, Arthritis Care and Research and the Annals of Internal Medicine. He is also a frequent reviewer for the New England Journal of Medicine, Lancet and Lancet Rheumatology.
    Research & Clinical Focus

    Rheumatoid Arthritis

    Development of bDMARDs and tsDMARDs

    Proper use of clinical metrics in publications and practice

    Clinical trial design in RA, OA, SLE, PsA and gout

    PsA

    SLE

  • Date Time Room Session Title Lecture Title
    Oct 21 12:00-12:40 Room A [Luncheon Symposium I - Pfizer] Practical Review of RA Treatment Option Tofacitinib in RA:Exploring the efficacy and safety profile in real-world experience